UBS Initiates Coverage on Paychex (PAYX) with a Buy; An Overlooked Story

UBS initiates coverage on Paychex (Nasdaq: PAYX) with a Buy rating. PT $37.

UBS analyst says,�"PAYX's leverage to an improving US small to mid-sized business (SMB) backdrop (100% of revenues; new business formation is key), favorable impact of an eventual interest rate increase, and attractive yield (4.1%) are keys. Sentiment should improve for core SMB (small/medium business) customers, which traditionally lag, and we expect revenue and EPS upside that is not currently contemplated in consensus estimates."

"We enjoy finding compelling, outside the box opportunities—and love it when stocks are simply overlooked. In our view, PAYX is the dictionary definition of a “consensus neutral,” offering an opportunity to take an early position ahead of an eventual rise in interest rates, which should be a major upside catalyst for the shares."

To See Ratings Summary & History on PAYX, Click Here

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• William Blair Starts First Advantage (FA) at Outperform, 'Best-in-Class Background Screener'
• Morgan Stanley Double Downgrades AU Optronics (2409:TT) (AUO) to Underweight
• Cantor Fitzgerald Starts Incyte (INCY) at Neutral, 'JAK-ing Up Its Pipeline In Advance of a Major Patent Cliff'